9.30 AM, Thursday 13th October
In this workshop at the UK BioIndustry Association (BIA) TechBio conference, Nicola will discuss how AI-based tools, underpinned by comprehensive biomedical data foundations, can be used to improve the target identification and triage process in drug discovery.
She will then join in a panel discussion chaired by Justin Bryans (Charles River Laboratories) with the other workshop speakers:
Nicola is Vice President of AI, and is responsible for BenevolentAI’s AI strategy and ensuring the company maintains its leading position in the AI-enabled drug discovery industry. Nicola has a PhD in pure mathematics and has worked at the intersection of AI and drug discovery for 22 years.